Section Arrow
Quote
DCOY.NASDAQ
- Decoy Therapeutics Inc.
Quotes are at least 15-min delayed:2026/04/25 18:44 EDT
Regular Hours
Last
 5.425
+0.005 (+0.09%)
Day High 
5.525 
Prev. Close
5.42 
1-M High
7.52 
Volume 
8.27K 
Bid
5.22
Ask
5.55
Day Low
5.2 
Open
5.2709 
1-M Low
5.285 
Market Cap 
2.88M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 5.86 
20-SMA 6.03 
50-SMA 7.3 
52-W High 415.8 
52-W Low 5.285 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-129.10/-187.84
Enterprise Value
2.88M
Balance Sheet
Book Value Per Share
11.07
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
838.14K
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
SCNIScinai Immunotherapeutics Ltd.0.737+0.281+61.62%0.15PE
ENVBEnveric Biosciences Inc.5.04+1.02+25.37%0PE
SGMOSangamo Therapeutics0.1901-0.0649-25.45%-- 
LNAILunai Bioworks Inc.0.3101+0.0054+1.77%-- 
IBRXImmunityBio7.44-0.75-9.16%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Decoy Therapeutics Inc is a pre-clinical stage biotechnology company focused on advancing its pipeline of peptide conjugate therapeutics engineered through its proprietary IMP3ACT platform. The IMP3ACT platform represents a paradigm shift in peptide conjugate drug discovery and manufacturing, leveraging machine learning (ML) and artificial intelligence (AI" tools alongside high-speed synthesis techniques to rapidly engineer, optimize and manufacture peptide conjugates that target serious unmet medical needs. The company manages its business in one operating segment, focused on the discovery and development therapeutics for patients with high, unmet medical needs. Its pipeline programs include: Pan-Coronavirus;and Tripledemic.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.